Our offerings under Regulation D Rule 506(c) are available to accredited investors only.
GENERALLY, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN 10% OF THE GREATER OF YOUR ANNUAL INCOME OR NET WORTH. DIFFERENT RULES APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(D)(2)(I)(C) OF REGULATION A. FOR GENERAL INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO WWW.INVESTOR.GOV

Obstacles Are The New Opportunities – David C. Karli

In this Show

David C. Karli is a Physician Entrepreneur and CEO of Greyledge Technologies. Watch as he introduces the concept of how his business started and how he pushed through the difficult obstacles.

When startups are just beginning, the first years are filled with intense challenges. Karli will go over in future posts about the difficulties start-up organizations face, specifically about Greyledge Technologies. He follows Grant Cardone’s advice on how to handle objections to price and sales.  Just like Grant, he has learned to see objections as opportunities.

Stay tuned to learn more about the pathway to success that Greyledge Technologies followed.

Get in contact with David C. Karli through his website, LinkedIn, and learn more about Greyledge Technologies here:

davidkarli.com

https://www.linkedin.com/in/davidkarli/

https://www.greyledgebiotech.com/

(Visited 5 times, 1 visits today)